Christopher E. Barbieri, M.D., Ph.D
Dr. Barbieri is a urologic surgeon whose long-term goal is definition of distinct molecular classes of prostate cancer, functional modeling of these subtypes to define drivers and therapeutic vulnerability, and translation of this information to care of prostate cancer patients. During his PhD training, he studied transcriptional targets of p53 family members, gaining extensive expertise in cancer biology and cell and molecular biology techniques. His post-doctoral work led to the identification and characterization SPOP mutations in prostate cancer, and the definition of SPOP mutant prostate cancer as a distinct molecular subclass. His research focuses on improving molecular classification of prostate cancer and identifying novel drivers, defining the signaling pathways and biology underlying distinct subtypes of the disease, and exposing new therapeutic avenues.
Michael Augello, Phd
PhD, Thomas Jefferson University
Research Focus: Evaluation of cistrome and transcriptional dynamics in response to tumor-associated changes in chromatin architecture and epigenetic modulators
Deli Liu, Phd
Ph.D. University of Georgia
B.A. China University of Petroleum
Research Focus: Impact of SPOP mutation on prognosis and clinical outcomes of prostate cancer; genomic and transcriptomic alteration of BPH.
Mirjam Blattner-Johnson, Phd Candidate
M.S. Humboldt University, Berlin
Research Focus: The role of mutated SPOP in development and progression of prostate cancer
BS, St. John’s University
Coordinates activities of the lab for smooth operations and support for laboratory staff including multiple post doctoral fellows, multiple laboratory technicians, resident fellows, graduate students, summer students and volunteers. Primarily responsible for coordination and oversight of efficient management of mouse colonies.
Research Technician II
BS, City University of New York, College of Staten Island
Laboratory Focus: Assisting in prostate cancer research involving mouse or human prostate cell lines and SPOP mutation.
Ramy Goueli, MD
Resident, Department of Urology
BS, Michigan State University
MD, Yale University School of Medicine
Research Focus: To determine the necessity of androgen in tumor initiation and maintenance in SPOP mutant prostate cancer.
Tomas A. Nazario
AA, Borough of Manhattan Community College
Office Responsibilities: Gatekeeper. Traige phone calls and messages; maintain physician's surgery, clinic and academic schedules; update medical charts.
Jinhee Park, ANP-BS, GNP, RN
M.S. in Nursing, Adult and Gerontology Nurse Practioner, CUNY Hunter College
B.S. in Nursing, Univeristy of Buffalo
Establish a medical and/or differential diagnosis based on history and clinical findings. Order and interpret diagnostic testing. Prescribe medications, as needed. Provide direct patient care to urology patients in collaboration with Dr. Barbieri. Perform direct patient care, education, interdisciplinary collaboration, research utilization, consultation and management of care plan. Provide adequate evaluations and interventions for multiple urologic conditions including urologic oncology, benign prostatic hyperplasia, nephrolithiasis, genitourinary infection, dysuria, hematuria etc.
525 east68th Street, Starr 900
New York, NY 10065